Optomed
3.795
EUR
+1.2 %
5,451 following
OPTOMED
NASDAQ Helsinki
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Income statement
Valuation
Quarterly estimates
Income statement
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 14.5 | 15.0 | 13.0 | 14.9 | 14.7 | 15.1 | 15.0 | 17.3 | 21.9 | 27.5 | 35.4 |
growth-% | 3.6 % | -13.1 % | 14.1 % | -1.3 % | 3.0 % | -0.4 % | 14.9 % | 26.5 % | 25.9 % | 28.6 % | |
EBITDA | 1.1 | -0.3 | -0.7 | -2.0 | -2.0 | -1.8 | -3.5 | -1.9 | 2.1 | 6.2 | 11.1 |
EBIT (adj.) | -0.7 | -2.6 | -2.9 | -4.8 | -5.1 | -3.7 | -6.0 | -4.7 | -2.4 | 0.3 | 4.6 |
EBIT | -0.7 | -2.6 | -2.9 | -4.8 | -5.1 | -4.0 | -6.0 | -4.7 | -2.4 | 0.3 | 4.6 |
Profit before taxes | -1.2 | -3.0 | -3.2 | -4.3 | -5.6 | -4.5 | -5.5 | -5.0 | -2.6 | -0.0 | 4.2 |
Net income | -1.3 | -2.9 | -3.2 | -4.2 | -5.5 | -4.4 | -5.5 | -5.0 | -2.6 | -0.0 | 4.2 |
EPS (adj.) | -0.16 | -0.32 | -0.24 | -0.31 | -0.38 | -0.25 | -0.29 | -0.26 | -0.13 | -0.00 | 0.22 |
growth-% | |||||||||||
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
Dividend ratio | 25.0 % |
Profitability and return on capital
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | 7.9 % | -2.2 % | -5.6 % | -13.5 % | -13.3 % | -11.8 % | -23.0 % | -10.9 % | 9.6 % | 22.4 % | 31.4 % |
EBIT-% (adj.) | -4.6 % | -17.3 % | -22.3 % | -32.2 % | -34.8 % | -24.3 % | -39.6 % | -27.1 % | -11.0 % | 1.1 % | 13.0 % |
EBIT-% | -4.6 % | -17.3 % | -22.3 % | -32.2 % | -34.8 % | -26.3 % | -39.6 % | -27.1 % | -11.0 % | 1.1 % | 13.0 % |
ROE | -20.4 % | -14.9 % | -22.9 % | -29.3 % | -21.8 % | -24.8 % | -23.5 % | -14.9 % | -0.0 % | 23.2 % | |
ROI | -10.7 % | -9.8 % | -18.9 % | -20.5 % | -15.5 % | -22.6 % | -18.2 % | -10.2 % | 1.7 % | 16.2 % |